Shopping Cart
Remove All
Your shopping cart is currently empty
Denintuzumab-MMAF, an ADC, combines a CD19-directed antibody with McMMAF and is utilized in researching acute lymphoblastic leukemia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Denintuzumab-MMAF, an ADC, combines a CD19-directed antibody with McMMAF and is utilized in researching acute lymphoblastic leukemia. |
| Synonyms | Anti-CD19 Reference Antibody |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | MMAF |
| Target | CD19 |
| Molecular Weight | 144.54 kDa |
| Storage | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.